Google News – FDA (biotech/pharma) External News
Life Sciences & Pharma Articles
Google News – Pharmaceuticals External News
ANI Pharmaceuticals (NASDAQ:ANIP) Earns Outperform Rating from Analysts at Leerink Partners - MarketBeat
Industry News External News
GLP-1 boom pushes pharma companies deeper into wellness, nutraceuticals - BusinessLine
Google News – Biopharma External News
Quantum BioPharma receives FDA clearance for MS phase 2 trial By Investing.com - Investing.com India
Google News – Biopharma External News
Celcuity at citigroup’s biopharma back to school summit: launch begins By Investing.com - Investing.com India
Google News – FDA (biotech/pharma) External News
FDA solidifies CDER, CBER leadership posts as commissioner confirmation awaits - fiercepharma.com
Google News – Biopharma External News
Propanc Biopharma plans phase 1b cancer trial in Australia - Investing.com
Google News – Biopharma External News
Can-Fite Biopharma Reports Clinical Improvement with Namodenoson in Decompensated Cirrhosis and Successful Bridging to Liver Transplantation - marketscreener.com
Google News – Biopharma External News
Quantum BioPharma Ltd. Secures FDA Clearance to Begin Phase 2 Trial of Lucid-MS for Multiple Sclerosis - Quiver Quantitative
Google News – Pharmaceuticals External News
Don't Ignore The Insider Selling In BioMarin Pharmaceutical - simplywall.st
Google News – Biopharma External News
Propanc Biopharma to Initiate World-First Phase 1b First-in-Human Study of PRP in February 2027 - marketscreener.com
Google News – Biopharma External News
Quantum BioPharma Ltd. NASDAQ: QNTM) Receives FDA Clearance to Begin Trials for Historic MS Treatment - Yahoo! Finance Canada
Google News – Biopharma External News
A cancer treatment is planned for its first human study in 2027. Up to 50 patients could take part. - Stock Titan
Google News – Biopharma External News
Quantum BioPharma Ltd. NASDAQ: QNTM) Receives FDA Clearance to Begin Trials for Historic MS Treatment - Yahoo Finance
Google News – Pharmaceuticals External News